Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Giaccone

Showing results (31-40 of 380) with videos related to

Pageof 38
Sort By:
Expert Opinion on Investigational Drugs|April 6, 2018
C-MET inhibitors for advanced non-small cell lung cancerGiulia Pasquini, Giuseppe Giaccone
Translational Lung Cancer Research|March 26, 2015
Intrapulmonary lymph node retrieval: unclear benefit for aggressive pathologic dissectionChristina Brzezniak, Giuseppe Giaccone
Translational Lung Cancer Research|March 26, 2015
Response to: intrapulmonary lymph node retrievalChristina Brzezniak, Giuseppe Giaccone
Seminars in Cancer Biology|May 27, 2023
Current knowledge of small cell lung cancer transformation from non-small cell lung cancerGiuseppe Giaccone, Yongfeng He
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|August 11, 2001
10th Conference on DNA Topoisomerases in therapyGiuseppe Giaccone, Giovanni Capranico
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 28, 2019
Author's ReplyGiuseppe Giaccone, Xiaoliang Zhao
Cancer Treatment Reviews|March 4, 2011
Strategies for overcoming resistance to EGFR family tyrosine kinase inhibitorsGiuseppe Giaccone, Yisong Wang
Cell Cycle (Georgetown, Tex.)|September 1, 2009
Met amplification and HSP90 inhibitorsGiuseppe Giaccone, Arun Rajan
Oncotargets and Therapy|October 17, 2022
Amivantamab in the Treatment of Metastatic NSCLC: Patient Selection and Special ConsiderationsIacopo Petrini, Giuseppe Giaccone
Current Opinion in Oncology|February 28, 2008
Antiangiogenic therapy in nonsmall cell lung cancerMartin Gutierrez, Giuseppe Giaccone
Pageof 38

Showing results (31-40 of 380) with videos related to

Sort By:
Pageof 38
Expert Opinion on Investigational Drugs|April 6, 2018
C-MET inhibitors for advanced non-small cell lung cancerGiulia Pasquini, Giuseppe Giaccone
Translational Lung Cancer Research|March 26, 2015
Intrapulmonary lymph node retrieval: unclear benefit for aggressive pathologic dissectionChristina Brzezniak, Giuseppe Giaccone
Translational Lung Cancer Research|March 26, 2015
Response to: intrapulmonary lymph node retrievalChristina Brzezniak, Giuseppe Giaccone
Seminars in Cancer Biology|May 27, 2023
Current knowledge of small cell lung cancer transformation from non-small cell lung cancerGiuseppe Giaccone, Yongfeng He
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|August 11, 2001
10th Conference on DNA Topoisomerases in therapyGiuseppe Giaccone, Giovanni Capranico
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 28, 2019
Author's ReplyGiuseppe Giaccone, Xiaoliang Zhao
Cancer Treatment Reviews|March 4, 2011
Strategies for overcoming resistance to EGFR family tyrosine kinase inhibitorsGiuseppe Giaccone, Yisong Wang
Cell Cycle (Georgetown, Tex.)|September 1, 2009
Met amplification and HSP90 inhibitorsGiuseppe Giaccone, Arun Rajan
Oncotargets and Therapy|October 17, 2022
Amivantamab in the Treatment of Metastatic NSCLC: Patient Selection and Special ConsiderationsIacopo Petrini, Giuseppe Giaccone
Current Opinion in Oncology|February 28, 2008
Antiangiogenic therapy in nonsmall cell lung cancerMartin Gutierrez, Giuseppe Giaccone
Pageof 38